GlaxoSmithKline | Koszty Operacyjne



Operating Expenses Zmiana Data
AbbVie USD 9.61B 6.98B 2025-03
Alcon AG USD 2.01B 102M 2025-03
Almirall EUR 485.13M 289.74M 2024-12
Amgen USD 6.86B 85M 2025-03
argenx SE USD 651.74M 16.37M 2025-03
AstraZeneca USD 9.91B 2.94B 2025-03
Bayer EUR 11.41B 3.22B 2025-03
Biogen USD 2.12B 106.5M 2025-03
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Eli Lilly USD 7.32B 1.06B 2025-03
Fresenius EUR 4.96B 197M 2025-03
Fresenius Medical Care EUR 4.55B 275.89M 2025-03
Galapagos EUR 233.68M 95.46M 2025-03
Genmab DKK 527M 3.72B 2025-03
Gilead Sciences USD 4.43B 687M 2025-03
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
Glaxosmithkline GBP 7.42B 408M 2024-12
GRIFOLS EUR 1.52B 87M 2025-03
Hikma Pharmaceutical USD 1.24B 87M 2024-06
Lonza CHF 2.52B 776M 2024-06
Merck EUR 4.22B 52M 2024-12
Merck USD 9.66B 1.67B 2025-03
Novartis USD 11.28B 1.73B 2024-12
Novo Nordisk 39.3B 1.81B 2025-03
Orion EUR 276.7M 65M 2025-03
Pfizer USD 10.05B 8.12B 2025-03
Philips EUR 3.94B 902M 2025-03
Recordati EUR 484.19M 89.46M 2025-03
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 8.32B 1.55B 2025-03
Smith & Nephew USD 2.65B 155M 2024-12
UCB EUR 1.23B 1.31B 2024-06



GlaxoSmithKline Koszty Operacyjne - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.